Epting D, Decker E, Ott E, Eisenberger T, Bader I, Bachmann N, Bergmann C. The ciliary transition zone protein TMEM218 synergistically interacts with the NPHP module and its reduced dosage leads to a wide range of syndromic ciliopathies. Hum Mol Genet (2022).
Gerstner L, Chen M, Kampf LL, Milosavljevic J, Lang K, …, Helmstädter M, Walz G, Hermle T. Inhibition of endoplasmic reticulum stress signaling rescues cytotoxicity of human apolipoprotein-L1 risk variants in Drosophila. Kidney Int (2022).
Choi M, Rübsam A, Schulz M, Decker E, Friedrich A, Schrezenmeier E, Halleck F, Eckardt KU, Bergmann C. Interstitial Nephritis: A Change in Diagnosis With Next-Generation Sequencing. Kidney Int Rep (2022).
Etges A, Hellmig N, Walenda G, Haddad BG, Machtens JP, Morosan T, Rump LC, Scholl UI. A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life. Nephron (2022).
Harder I, Münchhalfen M, Andrieux G, Börries M, Grimbacher B, …, Jellusova J, Warnatz K, Keller B. Dysregulated PI3K Signaling in B Cells of CVID Patients. Cells (2022).
Flum M, Dicks S, Teng YH, Schrempp M, Nyström A, Börries M, Hecht A. Canonical TGFβ signaling induces collective invasion in colorectal carcinogenesis through a Snail1- and Zeb1-independent partial EMT. Oncogene (2022).
Fayçal CA, Oszwald A, Feilen T, Cosenza-Contreras M, Schilling O, …, Rees AJ, Orend G, Kain R. An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition. Matrix Biol (2022).
Boeckhaus J, Hoefele J, Riedhammer KM, Nagel M, Beck BB, …, Bergmann C, …, Troesch V, Stock J, Gross O. Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study. Nephrol Dial Transplant (2022).
Treppner M, Binder H, Hess M. Interpretable generative deep learning: an illustration with single cell gene expression data. Hum Genet (2022).
Kind F, Fassbender TF, Andrieux G, Börries M, Meyer PT, Ruf J. Early PSA Change after [177Lu] PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival. Cancers (Basel) (2021).
Corrales E, Levit-Zerdoun E, Metzger P, Kowar S, Ku M, Brummer T, Börries M. Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts. Cell Commun Signal (2021).
Spohr C, Poggio T, Andrieux G, Schönberger K, Cabezas-Wallscheid N, Börries M, Halbach S, Illert AL, Brummer T. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo. Leukemia (2022).
Schlosser P, Tin A, Matias-Garcia PR, Thio CHL, Joehanes R,, …, Susztak K, Köttgen A, Teumer A. Meta-analyses identify DNA methylation associated with kidney function and damage. Nat Commun (2021).
Tin A, Schlosser P, Matias-Garcia PR, Thio CHL, Joehanes R, …, Susztak K, Teumer A, Köttgen A. Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus. Nat Commun (2021).
Mohamed M, Tellez J, Bergmann C, Gale DP, Sayer JA, Olinger E. Pseudodominant Alport syndrome caused by pathogenic homozygous and compound heterozygous COL4A3 splicing variants. Ann Hum Genet (2022).
Frey P, Devisme A, Rose K, Schrempp M, Freihen V, Andrieux G, Börries M, Hecht A. SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancer. Oncogene (2022).
